CA Patent

CA2132277C — Injection device

Assigned to F Hoffmann La Roche AG · Expires 2005-05-10 · 21y expired

What this patent protects

The device is used for introducing an active substance solution into a patient and has means for fastening to the skin and a cannula (9). The cannula is held in a withdrawn position by a retaining and releasing mechanism (14) before use and, after release, is propelled into the p…

USPTO Abstract

The device is used for introducing an active substance solution into a patient and has means for fastening to the skin and a cannula (9). The cannula is held in a withdrawn position by a retaining and releasing mechanism (14) before use and, after release, is propelled into the patient's skin. A connector (6) connected to the rear of the cannula serves to connect the cannula to an active substance reservoir.

Drugs covered by this patent

Patent Metadata

Patent number
CA2132277C
Jurisdiction
CA
Classification
—
Expires
2005-05-10
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.